CD4 and Parkinson disease: However, while the absence of CD3+ T cells or CD4+ T cells reportedly decelerates PD progression and ameliorate behavioral symptoms in mice treated with the PD driver 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the same does not hold true for the selective absence of CD8+ T cells102.